The phase II study of induction chemotherapy with cetuximab/S-1/low dose cisplatin for oral squamous cell carcinoma patients
Phase 2
- Conditions
- oral squamous cell carcinoma
- Registration Number
- JPRN-UMIN000014632
- Lead Sponsor
- The workshop of chemotherapy for oral cancer
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 55
Inclusion Criteria
Not provided
Exclusion Criteria
1)double cancer case 2)severe systemic complications 3)metastasis to CNS 4)ischemic heart disease 5)active gastrointestinal ulcer 6)severe mental disorder 7) women who are fertile or during pregnancy 8) past illness of severe drug allergy 9) attending doctor's decision as unsuitable patient for this study
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method histological effect (histological response rate)
- Secondary Outcome Measures
Name Time Method overall survival, disease-free survival, complication after surgery, the rate of avoidance of reconstructive surgery